Phase II study of pre-operative treatment with external radiotherapy plus panitumumab in operable locally advanced rectal cancer (favourable and intermediate prognostic group) (RaP Study/STAR-03)

Trial Profile

Phase II study of pre-operative treatment with external radiotherapy plus panitumumab in operable locally advanced rectal cancer (favourable and intermediate prognostic group) (RaP Study/STAR-03)

Recruiting
Phase of Trial: Phase II

Latest Information Update: 02 Jun 2015

At a glance

  • Drugs Panitumumab (Primary)
  • Indications Rectal cancer
  • Focus Therapeutic Use
  • Acronyms RaP/STAR-03
  • Most Recent Events

    • 02 Jun 2015 According to an abstract presented at the 51st Annual Meeting of the American Society of Clinical Oncology, 67 patients has been enrolled till Jan 2015.
    • 02 Jun 2015 Interim results (n=55) presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
    • 15 Jan 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top